Your browser doesn't support javascript.
HMGB1: A pleiotropic activity.
Colavita, Laura; Ciprandi, Giorgio; Salpietro, Annamaria; Cuppari, Caterina.
  • Colavita L; Unit of Pediatric Emergency, Department of Adult and Childhood Human Pathology, University Hospital of Messina, Messina, Italy.
  • Ciprandi G; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy.
  • Salpietro A; Pediatrics Clinic, ASST-Spedali Civili of Brescia, Brescia, Italy.
  • Cuppari C; Unit of Pediatric Emergency, Department of Adult and Childhood Human Pathology, University Hospital of Messina, Messina, Italy.
Pediatr Allergy Immunol ; 31 Suppl 26: 63-65, 2020 11.
Article in English | MEDLINE | ID: covidwho-944771
ABSTRACT
High-mobility group box 1 (HMGB1) is a nuclear protein involved in DNA replication, transcription, recombination, and repair. In the extracellular space, the HMGB1 plays an essential role in the onset and perpetuation of inflammation, belonging to the group of damage-associated molecular pattern (DAMP) molecules, also called alarmins. For this, HMGB1 has been studied in several acute and chronic inflammatory diseases as an early biomarker of inflammation. An increased concentration of HMGB1 has been detected in serum, as the expression of systemic inflammation, and in specific samples (such as stool, synovial fluid, nasal lavage fluid, sputum, and cerebrospinal fluid), as the expression of local production, in several infectious and/or inflammatory diseases. These data are particularly important because they open new futuristic possibilities for target therapies, potentially also for the COVID-19 treatment.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: HMGB1 Protein / SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Pediatr Allergy Immunol Journal subject: Allergy and Immunology / Pediatrics Year: 2020 Document Type: Article Affiliation country: Pai.13358

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HMGB1 Protein / SARS-CoV-2 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Pediatr Allergy Immunol Journal subject: Allergy and Immunology / Pediatrics Year: 2020 Document Type: Article Affiliation country: Pai.13358